| In millions, except per share items | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 | Sep-30-20 | Jun-30-20 | Jun-05-20 | Mar-31-20 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 8-K | 10-Q |
| Cash flows from operating activities: | | | | | | | | |
| Net income (loss) | -28.0 | -53.0 | -188.0 | -178.0 | -290.0 | -294.0 | | -233.0 |
| Adjustments to reconcile net income (loss) to net cash from (used in) operating activities: | | | | | | | | |
| Depreciation and amortization | 146.0 | 152.0 | 157.0 | 159.0 | 165.0 | 173.0 | | 221.0 |
| Amortization of deferred costs and other assets | 2.0 | | | 12.0 | 17.0 | 20.0 | | 27.0 |
| Gain on sales of real estate | -81.0 | -79.0 | -46.0 | | -59.0 | -32.0 | | |
| Gain on casualty | | -5.0 | -4.0 | -5.0 | -4.0 | -1.0 | | |
| Equity-based compensation expense | 9.0 | 10.0 | 10.0 | 10.0 | 10.0 | 10.0 | | 13.0 |
| Impairment loss | 4.0 | | | | | 54.0 | | |
| Deferred income tax expense | | | | -6.0 | -3.0 | | | |
| Changes in assets and liabilities: | | | | | | | | |
| Accounts receivable | 15.0 | 8.0 | 7.0 | 8.0 | -9.0 | | | -7.0 |
| Other assets | 13.0 | 13.0 | 14.0 | 7.0 | 6.0 | 5.0 | | 7.0 |
| Accounts payable and accrued expenses | -12.0 | -13.0 | -31.0 | -28.0 | -12.0 | -13.0 | | 4.0 |
| Other liabilities | | | | 0.0 | 1.0 | | | |
| Net cash provided by (used in) operating activities | 52.0 | 18.0 | -40.0 | -38.0 | 1.0 | 35.0 | | 121.0 |
| |
| Cash flows from investing activities: | | | | | | | | |
| Capital expenditures, primarily investments in existing real estate | -19.0 | -18.0 | -18.0 | -24.0 | -31.0 | -41.0 | | -83.0 |
| Lender and other escrows | -8.0 | -10.0 | -10.0 | | | -10.0 | | |
| Insurance proceeds related to real estate casualties | 11.0 | 11.0 | 15.0 | 15.0 | 9.0 | 11.0 | | 13.0 |
| Net cash provided by investing activities | 285.0 | 284.0 | 184.0 | 229.0 | 253.0 | 219.0 | | 184.0 |
| |
| Cash flows from financing activities: | | | | | | | | |
| Repayment of debt | -330.0 | -322.0 | -212.0 | -221.0 | -216.0 | -165.0 | | -164.0 |
| Debt issuance costs | | | -2.0 | | | -1.0 | | |
| Payment of insurance financing | -11.0 | -12.0 | -13.0 | -14.0 | -13.0 | -12.0 | | -13.0 |
| Dividends on common stock | | | | | | -45.0 | | -57.0 |
| Purchase of common stock | | -2.0 | | -1.0 | | | | |
| Net cash used in financing activities | -344.0 | -337.0 | -239.0 | -149.0 | -137.0 | -102.0 | | -139.0 |
| |
| The following table provides a reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amount shown in the condensed consolidated statements of cash flows: | | | | | | | | |
| Cash and cash equivalents | | | | | | | | |
| Restricted cash (included in other assets) | | | | | | | | |